JP2001515488A - ７−ヒドロキシ化されたステロイドの化粧用または皮膚科学用使用 - Google Patents

７−ヒドロキシ化されたステロイドの化粧用または皮膚科学用使用

Info

Publication number
JP2001515488A
JP2001515488A JP53928198A JP53928198A JP2001515488A JP 2001515488 A JP2001515488 A JP 2001515488A JP 53928198 A JP53928198 A JP 53928198A JP 53928198 A JP53928198 A JP 53928198A JP 2001515488 A JP2001515488 A JP 2001515488A
Authority
JP
Japan
Prior art keywords
formula
carbon atoms
dhea
skin
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP53928198A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001515488A5 (enExample
Inventor
ドレ、フェルナン、ジョゼフ
Original Assignee
ヴィタステロル（エス．ア．エル．エル）
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヴィタステロル（エス．ア．エル．エル） filed Critical ヴィタステロル（エス．ア．エル．エル）
Publication of JP2001515488A publication Critical patent/JP2001515488A/ja
Publication of JP2001515488A5 publication Critical patent/JP2001515488A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
JP53928198A 1997-03-10 1998-03-06 ７−ヒドロキシ化されたステロイドの化粧用または皮膚科学用使用 Ceased JP2001515488A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9702811A FR2760362B1 (fr) 1997-03-10 1997-03-10 Utilisation cosmetique ou dermatologique de steroides 7-hydroxyles
FR97/02811 1997-03-10
PCT/FR1998/000457 WO1998040074A1 (fr) 1997-03-10 1998-03-06 Utilisation cosmetique ou dermatologique de steroides 7-hydroxyles

Publications (2)

Publication Number Publication Date
JP2001515488A true JP2001515488A (ja) 2001-09-18
JP2001515488A5 JP2001515488A5 (enExample) 2004-11-25

Family

ID=9504568

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53928198A Ceased JP2001515488A (ja) 1997-03-10 1998-03-06 ７−ヒドロキシ化されたステロイドの化粧用または皮膚科学用使用

Country Status (8)

Country Link
US (2) US6407084B2 (enExample)
EP (1) EP0973524B1 (enExample)
JP (1) JP2001515488A (enExample)
AU (1) AU6840298A (enExample)
DE (1) DE69807454T2 (enExample)
ES (1) ES2183341T3 (enExample)
FR (1) FR2760362B1 (enExample)
WO (1) WO1998040074A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0908183A1 (en) * 1997-10-08 1999-04-14 Institute For Advanced Skin Research Inc. Dehydroepiandrosterone or derivatives thereof for increasing the content of hyaluronic acid in skin
EP1054677B1 (en) * 1998-11-19 2008-10-22 Connective Tissue Imagineering LLC Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides
FR2799645B1 (fr) * 1999-10-13 2004-04-30 Oreal Utilisation de la dhea ou de ses precurseurs ou derives metaboliques comme depigmentant
FR2803514B1 (fr) * 1999-10-13 2004-05-21 Oreal Compostion, notamment cosmetique, renfermant un steroide et un filtre uv liposoluble
GB0003524D0 (en) * 2000-02-15 2000-04-05 Btg Int Ltd Cytoprotective steroids (II)
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
FR2818135B1 (fr) 2000-12-15 2003-02-14 Oreal Composition, notamment cosmetique, renfermant la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un carotenoide
FR2818132B1 (fr) * 2000-12-15 2003-01-17 Oreal Utilisation de la 7-hydroxy dhea et/ou de la 7-ceto dhea pour traiter les desordres lies a une suractivite de la 5 alpha-reductase
FR2818148B1 (fr) 2000-12-15 2005-06-24 Oreal Composition,notamment cosmetique, renfermant, la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un isoflavonoide
FR2818149A1 (fr) * 2000-12-15 2002-06-21 Oreal Composition, notamment cosmetique, comprenant la 7-hydroxy dhea et/ou 7-ceto dhea et au moins un inhibiteur de 5 alpha-reductase
FR2827762A1 (fr) * 2001-07-24 2003-01-31 Oreal Utilisation de steroides comme amincissants
FR2828100B1 (fr) * 2001-08-02 2004-09-24 Galderma Res & Dev Composition de type emulsion inverse contenant de la dhea et/ou ses precurseurs ou derives, et ses utilisations en cosmetique et en dermatologie
FR2831440B1 (fr) * 2001-10-25 2003-12-26 Oreal Composition cosmetique, renfermant un derive de la dhea et un agent apaisant
FR2831441B1 (fr) 2001-10-25 2003-12-26 Oreal Utilisation cosmetique de derives de la dhea
US20020172647A1 (en) * 2002-03-06 2002-11-21 L'oreal Composition containing a steroid and a liposoluble UV filter
GB0403889D0 (en) * 2004-02-21 2004-03-24 Univ Edinburgh Uses of er-beta modulators
US8697152B2 (en) 2005-08-31 2014-04-15 Johnson & Johnson Consumer Companies, Inc. Anti-inflammatory compositions and personal care compositions comprising olive leaf (Olea europea) extract
US8758838B2 (en) 2005-08-31 2014-06-24 Johnson & Johnson Consumer Companies, Inc. Anti-inflammatory compositions and methods of use
SI1963280T1 (sl) 2005-12-22 2016-02-29 Newron Pharmaceuticals S.P.A. 2-feniletilamino derivati kot modulatorji kalcijevih in/ali natrijevih kanalčkov

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1076001B (it) * 1977-01-04 1985-04-22 Also Lab Di Dr P Sorbini & C S Composizione per il trattamento del cuoio capelluto e contro la caduta dei capelli
US4496556A (en) * 1982-08-16 1985-01-29 Norman Orentreich Topical applications for preventing dry skin
GB8417895D0 (en) * 1984-07-13 1984-08-15 Marples B A Pharmaceutical anti-fungal composition
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
US5461042A (en) * 1988-12-30 1995-10-24 Loria; Roger M. Regulation of the immune system
FR2696934B1 (fr) * 1992-10-20 1995-06-02 Conservatoire Nal Arts Metiers Dérivés de stéroïdes naturels 3B hydroxyles ayant des propriétés de déclenchement et de stimulation de l'immunité, composition les contenant et procédé pour les obtenir.
ZA947912B (en) * 1993-10-12 1995-05-24 Broadbent J W Nominees Pty Ltd Treatment of medical disorders associated with free radical formation
FR2729854A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
PL334840A1 (en) * 1997-01-24 2000-03-27 Univ California Application of fxr, pparalpha and lxralpha activators in order to restore the barrier function, to stimulate epithelium differentation and to inhibit proliferation

Also Published As

Publication number Publication date
AU6840298A (en) 1998-09-29
FR2760362A1 (fr) 1998-09-11
FR2760362B1 (fr) 2000-08-11
EP0973524B1 (fr) 2002-08-28
ES2183341T3 (es) 2003-03-16
EP0973524A1 (fr) 2000-01-26
US20010041696A1 (en) 2001-11-15
DE69807454D1 (de) 2002-10-02
US6620803B2 (en) 2003-09-16
US20020165214A1 (en) 2002-11-07
DE69807454T2 (de) 2003-04-17
WO1998040074A1 (fr) 1998-09-17
US6407084B2 (en) 2002-06-18

Similar Documents

Publication Publication Date Title
JP2001515488A (ja) ７−ヒドロキシ化されたステロイドの化粧用または皮膚科学用使用
DE69433994T2 (de) Therapeutische verwendungen und verabreichungsysteme von dehydroepiandrosteron
Strauss et al. The effect of androgens and estrogens on human sebaceous glands
US6110966A (en) Triple action complex
DE19619045C1 (de) Verwendung von Kombinationspräparaten zur Behandlung hypogonadaler Männer sowie Männern mit Hypophysenerkrankungen
FR2884713A1 (fr) Kit steroidique et composition pouvant mousser et utilisation de ceux-ci
EP3002290A2 (en) Synthesis of deoxycholic acid (dca)
CH648211A5 (de) Mittel zur prophylaxe und therapie der prostatahyperplasie.
EP1414467B1 (de) Topische behandlung bei der mastalgie
Celasco et al. Biological profile of cortexolone 17a-propionate (CB-03-01), a new topical and peripherally selective androgen antagonist
Ellinwood et al. Effect of inhibition of estrogen synthesis during the luteal phase on function of the corpus luteum in rhesus monkeys
EP0885005A2 (de) Kombination von dehydroepiandrosteron und aromatasehemmern und verwendung dieser kombination zur herstellung eines arzneimittels zur behandlung eines relativen und absoluten androgenmangels beim mann
EP1123100B1 (en) Improving memory by the administration of delta 5-androstene-3 beta-ol-7,17-dione and 3 beta esters thereof
JPH11510144A (ja) 細胞に神経保護を付与するための薬剤の製造のための非エストロゲン多環式フェノール化合物の使用
US4593021A (en) Treatment of skin over androgenicity using compositions containing pregnenolone
EP0399631B1 (en) Use of gestodene for the production of pharmaceutical agents
US4622317A (en) Treatment of skin over androgenicity using compositions containing pregnenolone
US20060292185A1 (en) Topical skin preparations for treatment of skin aging comprising a testosterone ester
EP0240630A2 (en) Treatment of skin of over androgenicity using compositions containing pregnenolone
Ruppert et al. The role of aromatization in the development of sexual behavior of the female hamster (Mesocricetus auratus)
FUKUSHIMA et al. Sterol and steroid metabolism
Gruber et al. Anti-aging and Esthetic Endocrinology
US8530435B2 (en) Brassinosteroids in treating prostatic hyperplasia and androgenic alopecia
GB2131292A (en) Progestational pharmaceutical formulations
Fehér et al. Excretion of Individual Unconjugated 17-Oxosteroids by Normal Female Subjects

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040219

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040219

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080201

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080219

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080205

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20080708

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080909